Publications
Research outputs
Publications from the Save Sight Registries and related research, across all of our condition specific projects. Use the filters to narrow the list by year, publication type, registry or author.
Macular Atrophy in the Better-Seeing Eye of Australian Patients Treated for Neovascular Age-Related Macular Degeneration Journal Article
In: Clinical and Experimental Ophthalmology, vol. 54, no. 2, pp. 295–297, 2026, ISSN: 1442-9071.
Twelve-Month Real-World Outcomes of Faricimab for Treatment-Naive Neovascular AMD in Australia Journal Article
In: Clinical and Experimental Ophthalmology, vol. 54, no. 4, pp. 500–506, 2026, ISSN: 1442-9071.
Intravitreal faricimab in patients with nAMD: French data from the Fight Retinal Blindness! Registry Journal Article
In: Acta Ophthalmologica, 2026, ISSN: 1755-3768.
The Fight Retinal Blindness! registry: An international treatment outcomes registry for retinal diseases Journal Article
In: Annals of Clinical Epidemiology, vol. 8, no. 1, pp. 28–35, 2026, ISSN: 2434-4338.
Twelve-Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! Registry Journal Article
In: Clinical and Experimental Ophthalmology, vol. 54, no. 2, pp. 233–240, 2026, ISSN: 1442-9071.
Suspending vascular endothelial growth factor inhibitors in eyes with retinal vein occlusion Journal Article
In: British Journal of Ophthalmology, 2026, ISSN: 1468-2079.
In: Ophthalmology Retina, vol. 10, no. 8, pp. 833–843, 2026, ISSN: 2468-6530.
Outcomes of eyes with persistent diabetic macular oedema: The Fight Retinal Blindness! Project Journal Article
In: British Journal of Ophthalmology, 2026, ISSN: 1468-2079.
In: Clinical and Experimental Ophthalmology, 2026, ISSN: 1442-9071.
When Retention Becomes an Outcome: Disentangling Faricimab Durability and Care Access-Response Journal Article
In: Clinical and Experimental Ophthalmology, 2026, ISSN: 1442-9071.
In: British Journal of Ophthalmology, vol. 110, no. 8, pp. 892–898, 2026, ISSN: 1468-2079.
In: Canadian Journal of Ophthalmology, vol. 61, no. 5, pp. 1215–1225, 2026, ISSN: 1715-3360.
In: Ophthalmology and Therapy, vol. 15, no. 8, pp. 2797–2811, 2026, ISSN: 2193-6528.
Outlier ophthalmologists in the treatment of neovascular age-related macular degeneration with intravitreal therapy Journal Article
In: British Journal of Ophthalmology, vol. 109, no. 5, pp. 606–613, 2025, ISSN: 1468-2079.
Differentiating treatment episodes from gaps in eyes with diabetic macular oedema Journal Article
In: British Journal of Ophthalmology, vol. 109, no. 11, pp. 1279–1282, 2025, ISSN: 1468-2079.
Progression of Loss of Vision From Centre-Involving Macular Atrophy in Eyes Treated for nAMD Journal Article
In: Clinical and Experimental Ophthalmology, vol. 53, no. 8, pp. 925–935, 2025, ISSN: 1442-9071.
Outcomes After Switching to Faricimab in Neovascular Age-Related Macular Degeneration: Data From the Fight Retinal Blindness! Registry Journal Article
In: Clinical and Experimental Ophthalmology, vol. 53, no. 9, pp. 1156–1167, 2025, ISSN: 1442-9071.
Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGF Journal Article
In: Ophthalmology and Therapy, vol. 14, no. 8, pp. 1813–1826, 2025, ISSN: 2193-6528.
In: Eye, vol. 39, no. 12, pp. 2407–2414, 2025, ISSN: 1476-5454.
In: Eye, vol. 39, no. 18, pp. 3306–3313, 2025, ISSN: 1476-5454.

